DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Cepharanthine
Cepharanthine
Combined Effects of Celecoxib and Cepharanthine on Human Colorectal Cancer Cells in Vitro
Specifications of Approved Drug Compound Library
&
(12) United States Patent (10) Patent No.: US 9,636.405 B2 Tamarkin Et Al
(12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr
Anticancer Effects of Cepharanthine on Human Colon Cancer Cells ฤทธิ์ต้านมะเร็งของเซฟราเรนทีนต่อเซลล์มะเร็งล�ำไส้ใหญ่ของมนุษย์
SAR News No.40
Stephania Delavayi Diels. Inhibits Breast Carcinoma Proliferation Through the P38 MAPK/NF-Κb/COX-2 Pathway
(12) United States Patent (10) Patent No.: US 8,900,602 B2 Fujiwara Et Al
Methoxy-3-Veratryl-5,6-Dihydrobenzoglyoxalocoline T
Novel Modulation of Adenylyl Cyclase Type 2 Jason Michael Conley Purdue University
Different Viewpoints on Tapering Dmards in Rheumatoid Arthritis Verschillende Perspectieven Op Het Afbouwen Van Dmards Bij Reumatoïde Artritis
Known Bioactive Library: Selleck Bioactive 10Mm, 3.33Mm, 1.11Mm
199425127.Pdf
(12) Patent Application Publication (10) Pub. No.: US 2016/0220537 A1 GARNER Et Al
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Identification of Endogenous Function and Substrate-Dependent Interactions of Organic Cation Transporter 1
Suppl Table 2.Xlsx
Top View
Electronic Supplementary Material (ESI) for Organic & Biomolecular
WO 2013/179143 A2 5 December 2013 (05.12.2013) P O P C T
Osteoarthritis Guideline Appendix 4 – Search Strategies
(12) United States Patent (10) Patent No.: US 9,549,898 B2 Tamarkin Et Al
JIA Guideline Appendix 4
Figure S1. Rhod 2 Staining of Intracellular Calcium Depletion
Supplementary Table 3
Supplementary Materials
JIA Uveitis Guideline Appendix 3
WO 2012/170676 Al 13 December 2012 (13.12.2012) P O P C T
3 Rd International Multidisciplinary Symposium on Drug Research and Development - DRD 2017
We Can Provide Premium Tailor-Made Products to Fit Each Customer Need
Us 2008/0206161 A1 S. Valve
Drug Discovery Kits
Supplementary Information